(Q47822666)

5 February 2018

title

Fractionated stereotactic radiotherapy boost after post-operative radiotherapy in patients with high-grade gliomas. (English)

1 reference

5 February 2018

adaptive radiation therapy

main subject

0 references

author name string

Brigitta G Baumert

1

1 reference

5 February 2018

Johannes Lutterbach

2

1 reference

5 February 2018

René Bernays

3

1 reference

5 February 2018

J Bernard Davis

4

1 reference

5 February 2018

Frank L Heppner

5

1 reference

5 February 2018

publication date

1 May 2003

1 reference

5 February 2018

Radiotherapy and Oncology

published in

1 reference

5 February 2018

volume

67

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

page(s)

183-190

1 reference

5 February 2018

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Linac radiosurgery for high-grade gliomas: the University of Florida experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Accelerated radiotherapy regimen for malignant gliomas using stereotactic concomitant boosts for dose escalation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Selection bias, survival, and brachytherapy for glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Relocatable frame for stereotactic external beam radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

A non-invasive, relocatable stereotactic frame for fractionated radiotherapy and multiple imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

External irradiation followed by an interstitial high activity iodine-125 implant “boost” in the initial treatment of malignant gliomas: NCOG study 6G-82-2 gliomas: NCOG study 6H-82-2

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Moving targets and ghosts of the past: outcome measurement in brain tumour therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Stereotactic radiosurgery for recurrent malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

A non-invasive method for fractionated stereotactic irradiation of brain tumors with linear accelerator

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Accelerated hyperfractionated radiotherapy in 149 patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Stereotactic radiosurgery for glioblastoma: a final report of 31 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

A population-based study of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Stereotactically guided fractionated radiotherapy: technical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Radiotherapy for high grade gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Radiosurgery and accelerated radiotherapy for patients with glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Hypofractionated stereotactic radiotherapy in the management of recurrent glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Prognostic factors for high-grade malignant glioma: development of a prognostic index. A Report of the Medical Research Council Brain Tumour Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Intensity-modulated radiotherapy with an integrated boost to the macroscopic tumor volume in the treatment of high-grade gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Value of radiosurgery in first-line therapy of glioblastoma multiforme. The Heidelberg experience and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900386-9

7 January 2021

10.1016/S0167-8140(02)00386-9

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018